Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 549 DKK 2.91%
Market Cap: 39B DKK

P/OCF
Price to OCF

-41.7
Current
-19.5
Median
20.4
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-41.7
=
Market Cap
38.3B DKK
/
Operating Cash Flow
-930.8m DKK
Market Cap P/OCF
DK
Zealand Pharma A/S
CSE:ZEAL
38.3B DKK -41.7
FR
Pharnext SCA
OTC:PNEXF
6T USD -230 913.9
US
Abbvie Inc
NYSE:ABBV
357.9B USD 19
US
Amgen Inc
NASDAQ:AMGN
164.2B USD 14.3
US
Gilead Sciences Inc
NASDAQ:GILD
138.5B USD 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
129.1B USD -262.1
US
Epizyme Inc
F:EPE
94.1B EUR -487.2
AU
CSL Ltd
ASX:CSL
121.8B AUD 26.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
69.7B USD 15.8
US
Seagen Inc
F:SGT
39.3B EUR -78.6
NL
argenx SE
XBRU:ARGX
33.1B EUR -137.5
 
DK
Zealand Pharma A/S
CSE:ZEAL
Average P/OCF: 17.6
Negative Multiple: -41.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -230 913.9
US
Abbvie Inc
NYSE:ABBV
19
US
Amgen Inc
NASDAQ:AMGN
14.3
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -262.1
US
E
Epizyme Inc
F:EPE
Negative Multiple: -487.2
AU
CSL Ltd
ASX:CSL
26.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -78.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -137.5

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A